| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3
|
|
ABCC6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5
|
|
ADCY7
|
adenylate cyclase 7
|
|
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary)
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADORA2B
|
adenosine A2b receptor
|
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
AMBN
|
ameloblastin (enamel matrix protein)
|
|
AMER1
|
APC membrane recruitment protein 1
|
|
AMOTL2
|
angiomotin like 2
|
|
ANXA2
|
annexin A2
|
|
APOA1
|
apolipoprotein A-I
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP5
|
aquaporin 5
|
|
AR
|
androgen receptor
|
|
ARF6
|
ADP-ribosylation factor 6
|
|
ARFGEF2
|
ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited)
|
|
ARHGEF25
|
Rho guanine nucleotide exchange factor (GEF) 25
|
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7
|
|
ARPC1B
|
actin related protein 2/3 complex, subunit 1B, 41kDa
|
|
ASGR1
|
asialoglycoprotein receptor 1
|
|
ATF1
|
activating transcription factor 1
|
|
ATF4
|
activating transcription factor 4
|
|
ATF5
|
activating transcription factor 5
|
|
ATF6
|
activating transcription factor 6
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATMIN
|
ATM interactor
|
|
ATXN3
|
ataxin 3
|
|
AURKA
|
aurora kinase A
|
|
AVEN
|
apoptosis, caspase activation inhibitor
|
|
AZI2
|
5-azacytidine induced 2
|
|
B4GALT5
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5
|
|
BACH1
|
BTB and CNC homology 1, basic leucine zipper transcription factor 1
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BATF
|
basic leucine zipper transcription factor, ATF-like
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRS3
|
bombesin-like receptor 3
|
|
BSG
|
basigin (Ok blood group)
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTG2
|
BTG family, member 2
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
CA1
|
carbonic anhydrase I
|
|
CADPS
|
Ca++-dependent secretion activator
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CARF
|
calcium responsive transcription factor
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CCNT1
|
cyclin T1
|
|
CD14
|
CD14 molecule
|
|
CD200R1
|
CD200 receptor 1
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD80
|
CD80 molecule
|
|
CDCA5
|
cell division cycle associated 5
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK11B
|
cyclin-dependent kinase 11B
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
|
CDK8
|
cyclin-dependent kinase 8
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEBPE
|
CCAAT/enhancer binding protein (C/EBP), epsilon
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHP1
|
calcineurin-like EF-hand protein 1
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CIC
|
capicua transcriptional repressor
|
|
CISD1
|
CDGSH iron sulfur domain 1
|
|
CNN2
|
calponin 2
|
|
COIL
|
coilin
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CPEB1
|
cytoplasmic polyadenylation element binding protein 1
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREB3L1
|
cAMP responsive element binding protein 3-like 1
|
|
CREBBP
|
CREB binding protein
|
|
CREM
|
cAMP responsive element modulator
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTGF
|
connective tissue growth factor
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSB
|
cathepsin B
|
|
CTTN
|
cortactin
|
|
CUX1
|
cut-like homeobox 1
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
DAO
|
D-amino-acid oxidase
|
|
DAOA
|
D-amino acid oxidase activator
|
|
DDX5
|
DEAD (Asp-Glu-Ala-Asp) box helicase 5
|
|
DEF6
|
differentially expressed in FDCP 6 homolog (mouse)
|
|
DGCR8
|
DGCR8 microprocessor complex subunit
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DLK1
|
delta-like 1 homolog (Drosophila)
|
|
DLL1
|
delta-like 1 (Drosophila)
|
|
DMC1
|
DNA meiotic recombinase 1
|
|
DNM2
|
dynamin 2
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DOCK1
|
dedicator of cytokinesis 1
|
|
DOCK4
|
dedicator of cytokinesis 4
|
|
DOK2
|
docking protein 2, 56kDa
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD2
|
dopamine receptor D2
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DUSP4
|
dual specificity phosphatase 4
|
|
DVL3
|
dishevelled segment polarity protein 3
|
|
DYNLL1
|
dynein, light chain, LC8-type 1
|
|
DYRK1B
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F5
|
E2F transcription factor 5, p130-binding
|
|
E2F8
|
E2F transcription factor 8
|
|
EDN1
|
endothelin 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2AK4
|
eukaryotic translation initiation factor 2 alpha kinase 4
|
|
EIF4G2
|
eukaryotic translation initiation factor 4 gamma, 2
|
|
EN1
|
engrailed homeobox 1
|
|
EN2
|
engrailed homeobox 2
|
|
EP300
|
E1A binding protein p300
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESCO2
|
establishment of sister chromatid cohesion N-acetyltransferase 2
|
|
ESPL1
|
extra spindle pole bodies homolog 1 (S. cerevisiae)
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETV4
|
ets variant 4
|
|
ETV6
|
ets variant 6
|
|
EYA2
|
EYA transcriptional coactivator and phosphatase 2
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FAM120A
|
family with sequence similarity 120A
|
|
FAP
|
fibroblast activation protein, alpha
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FES
|
FES proto-oncogene, tyrosine kinase
|
|
FEZF2
|
FEZ family zinc finger 2
|
|
FGA
|
fibrinogen alpha chain
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF4
|
fibroblast growth factor 4
|
|
FGF5
|
fibroblast growth factor 5
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGG
|
fibrinogen gamma chain
|
|
FKBP8
|
FK506 binding protein 8, 38kDa
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP3
|
forkhead box P3
|
|
FRMPD1
|
FERM and PDZ domain containing 1
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
FUBP1
|
far upstream element (FUSE) binding protein 1
|
|
FUSE
|
polykaryocytosis promoter
|
|
FXN
|
frataxin
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
FZD5
|
frizzled class receptor 5
|
|
FZR1
|
fizzy/cell division cycle 20 related 1 (Drosophila)
|
|
GAS6
|
growth arrest-specific 6
|
|
GCG
|
glucagon
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GCKR
|
glucokinase (hexokinase 4) regulator
|
|
GDF3
|
growth differentiation factor 3
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GH1
|
growth hormone 1
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLI2
|
GLI family zinc finger 2
|
|
GLI3
|
GLI family zinc finger 3
|
|
GLIS2
|
GLIS family zinc finger 2
|
|
GLUD1
|
glutamate dehydrogenase 1
|
|
GM2A
|
GM2 ganglioside activator
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GPSM1
|
G-protein signaling modulator 1
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSN
|
gelsolin
|
|
GTF2F1
|
general transcription factor IIF, polypeptide 1, 74kDa
|
|
GUCY1A2
|
guanylate cyclase 1, soluble, alpha 2
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
HABP2
|
hyaluronan binding protein 2
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HBG1
|
hemoglobin, gamma A
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC3
|
histone deacetylase 3
|
|
HEXB
|
hexosaminidase B (beta polypeptide)
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HGFAC
|
HGF activator
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HK2
|
hexokinase 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPAB
|
heterogeneous nuclear ribonucleoprotein A/B
|
|
HNRNPC
|
heterogeneous nuclear ribonucleoprotein C (C1/C2)
|
|
HOXA10
|
homeobox A10
|
|
HOXA11
|
homeobox A11
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSF4
|
heat shock transcription factor 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HTATIP2
|
HIV-1 Tat interactive protein 2, 30kDa
|
|
HUS1
|
HUS1 checkpoint homolog (S. pombe)
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
IER2
|
immediate early response 2
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF2
|
insulin-like growth factor 2
|
|
IL10
|
interleukin 10
|
|
IL12RB2
|
interleukin 12 receptor, beta 2
|
|
IL13
|
interleukin 13
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL2
|
interleukin 2
|
|
IL22
|
interleukin 22
|
|
IL6
|
interleukin 6
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IL7R
|
interleukin 7 receptor
|
|
IL9
|
interleukin 9
|
|
IL9R
|
interleukin 9 receptor
|
|
ILF2
|
interleukin enhancer binding factor 2
|
|
ILF3
|
interleukin enhancer binding factor 3, 90kDa
|
|
ILK
|
integrin-linked kinase
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF7
|
interferon regulatory factor 7
|
|
ISL1
|
ISL LIM homeobox 1
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3BP
|
integrin beta 3 binding protein (beta3-endonexin)
|
|
ITGB6
|
integrin, beta 6
|
|
IVL
|
involucrin
|
|
JAG1
|
jagged 1
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JUN
|
jun proto-oncogene
|
|
JUNB
|
jun B proto-oncogene
|
|
JUND
|
jun D proto-oncogene
|
|
JUP
|
junction plakoglobin
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KBTBD7
|
kelch repeat and BTB (POZ) domain containing 7
|
|
KCND3
|
potassium channel, voltage gated Shal related subfamily D, member 3
|
|
KCNIP2
|
Kv channel interacting protein 2
|
|
KCNJ12
|
potassium channel, inwardly rectifying subfamily J, member 12
|
|
KCNQ2
|
potassium channel, voltage gated KQT-like subfamily Q, member 2
|
|
KCNQ3
|
potassium channel, voltage gated KQT-like subfamily Q, member 3
|
|
KDR
|
kinase insert domain receptor
|
|
KIAA0586
|
KIAA0586
|
|
KIF5B
|
kinesin family member 5B
|
|
KITLG
|
KIT ligand
|
|
KL
|
klotho
|
|
KLF1
|
Kruppel-like factor 1 (erythroid)
|
|
KLF11
|
Kruppel-like factor 11
|
|
KLF14
|
Kruppel-like factor 14
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF9
|
Kruppel-like factor 9
|
|
KLHDC10
|
kelch domain containing 10
|
|
KLK14
|
kallikrein-related peptidase 14
|
|
KLK7
|
kallikrein-related peptidase 7
|
|
KNG1
|
kininogen 1
|
|
LATS2
|
large tumor suppressor kinase 2
|
|
LBH
|
limb bud and heart development
|
|
LECT1
|
leukocyte cell derived chemotaxin 1
|
|
LEP
|
leptin
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS8
|
lectin, galactoside-binding, soluble, 8
|
|
LIF
|
leukemia inhibitory factor
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LILRB4
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
|
|
LIMD1
|
LIM domains containing 1
|
|
LIN9
|
lin-9 DREAM MuvB core complex component
|
|
LMTK1
|
lemur tail kinase 1
|
|
LNPEP
|
leucyl/cystinyl aminopeptidase
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LTB4R2
|
leukotriene B4 receptor 2
|
|
MAG
|
myelin associated glycoprotein
|
|
MAGEA11
|
melanoma antigen family A11
|
|
MAML1
|
mastermind-like 1 (Drosophila)
|
|
MAP2K3
|
mitogen-activated protein kinase kinase 3
|
|
MAP3K2
|
mitogen-activated protein kinase kinase kinase 2
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAP4K4
|
mitogen-activated protein kinase kinase kinase kinase 4
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK11
|
mitogen-activated protein kinase 11
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPT
|
microtubule-associated protein tau
|
|
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor)
|
|
MASP2
|
mannan-binding lectin serine peptidase 2
|
|
MBD1
|
methyl-CpG binding domain protein 1
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MBOAT4
|
membrane bound O-acyltransferase domain containing 4
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED1
|
mediator complex subunit 1
|
|
MED25
|
mediator complex subunit 25
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFGE8
|
milk fat globule-EGF factor 8 protein
|
|
MFI2
|
antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5
|
|
MIR106B
|
microRNA 106b
|
|
MIR124-1
|
microRNA 124-1
|
|
MIR143
|
microRNA 143
|
|
MIR146A
|
microRNA 146a
|
|
MIR155
|
microRNA 155
|
|
MIR181A1
|
microRNA 181a-1
|
|
MIR193A
|
microRNA 193a
|
|
MIR193B
|
microRNA 193b
|
|
MIR21
|
microRNA 21
|
|
MIR361
|
microRNA 361
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MLXIPL
|
MLX interacting protein-like
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP16
|
matrix metallopeptidase 16 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP20
|
matrix metallopeptidase 20
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MRC2
|
mannose receptor, C type 2
|
|
MST1
|
macrophage stimulating 1
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUL1
|
mitochondrial E3 ubiquitin protein ligase 1
|
|
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCBP2
|
MYC binding protein 2, E3 ubiquitin protein ligase
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
NAB2
|
NGFI-A binding protein 2 (EGR1 binding protein 2)
|
|
NANOG
|
Nanog homeobox
|
|
NBN
|
nibrin
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NCOA6
|
nuclear receptor coactivator 6
|
|
NDUFA13
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13
|
|
NEK2
|
NIMA-related kinase 2
|
|
NELFB
|
negative elongation factor complex member B
|
|
NEUROD1
|
neuronal differentiation 1
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFATC3
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFIB
|
nuclear factor I/B
|
|
NFIX
|
nuclear factor I/X (CCAAT-binding transcription factor)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NFKBIZ
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta
|
|
NFX1
|
nuclear transcription factor, X-box binding 1
|
|
NFYA
|
nuclear transcription factor Y, alpha
|
|
NGLY1
|
N-glycanase 1
|
|
NLRC4
|
NLR family, CARD domain containing 4
|
|
NNMT
|
nicotinamide N-methyltransferase
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOX1
|
NADPH oxidase 1
|
|
NOX4
|
NADPH oxidase 4
|
|
NOXA1
|
NADPH oxidase activator 1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
NSMAF
|
neutral sphingomyelinase (N-SMase) activation associated factor
|
|
OAS3
|
2'-5'-oligoadenylate synthetase 3, 100kDa
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
OSM
|
oncostatin M
|
|
PAF1
|
Paf1, RNA polymerase II associated factor, homolog (S. cerevisiae)
|
|
PAIP1
|
poly(A) binding protein interacting protein 1
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX3
|
paired box 3
|
|
PAX5
|
paired box 5
|
|
PAX8
|
paired box 8
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDE4A
|
phosphodiesterase 4A, cAMP-specific
|
|
PDE6B
|
phosphodiesterase 6B, cGMP-specific, rod, beta
|
|
PDGFC
|
platelet derived growth factor C
|
|
PDGFD
|
platelet derived growth factor D
|
|
PDPN
|
podoplanin
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PFKFB3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
|
|
PFN2
|
profilin 2
|
|
PGAM5
|
phosphoglycerate mutase family member 5
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PI4KB
|
phosphatidylinositol 4-kinase, catalytic, beta
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIM2
|
Pim-2 proto-oncogene, serine/threonine kinase
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PITHD1
|
PITH (C-terminal proteasome-interacting domain of thioredoxin-like) domain containing 1
|
|
PKM
|
pyruvate kinase, muscle
|
|
PKN1
|
protein kinase N1
|
|
PKP2
|
plakophilin 2
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCB3
|
phospholipase C, beta 3 (phosphatidylinositol-specific)
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLG
|
plasminogen
|
|
PODXL
|
podocalyxin-like
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
PON2
|
paraoxonase 2
|
|
POU3F2
|
POU class 3 homeobox 2
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
POU5F1B
|
POU class 5 homeobox 1B
|
|
PPAPDC1B
|
phosphatidic acid phosphatase type 2 domain containing 1B
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme
|
|
PPP5C
|
protein phosphatase 5, catalytic subunit
|
|
PPP6C
|
protein phosphatase 6, catalytic subunit
|
|
PRCP
|
prolylcarboxypeptidase (angiotensinase C)
|
|
PRDX6
|
peroxiredoxin 6
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKRA
|
protein kinase, interferon-inducible double stranded RNA dependent activator
|
|
PRL
|
prolactin
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PRSS57
|
protease, serine, 57
|
|
PSMA3
|
proteasome (prosome, macropain) subunit, alpha type, 3
|
|
PSMB5
|
proteasome (prosome, macropain) subunit, beta type, 5
|
|
PSMD4
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4
|
|
PSME1
|
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha)
|
|
PSME3
|
proteasome (prosome, macropain) activator subunit 3 (PA28 gamma; Ki)
|
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain)
|
|
PTGIS
|
prostaglandin I2 (prostacyclin) synthase
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTN
|
pleiotrophin
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRE
|
protein tyrosine phosphatase, receptor type, E
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
RABEP2
|
rabaptin, RAB GTPase binding effector protein 2
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD1
|
RAD1 checkpoint DNA exonuclease
|
|
RAD23A
|
RAD23 homolog A (S. cerevisiae)
|
|
RAD23B
|
RAD23 homolog B (S. cerevisiae)
|
|
RAD51
|
RAD51 recombinase
|
|
RAD9A
|
RAD9 homolog A (S. pombe)
|
|
RANBP2
|
RAN binding protein 2
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAP1GDS1
|
RAP1, GTP-GDP dissociation stimulator 1
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RASAL1
|
RAS protein activator like 1 (GAP1 like)
|
|
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated)
|
|
RASGRP3
|
RAS guanyl releasing protein 3 (calcium and DAG-regulated)
|
|
RB1
|
retinoblastoma 1
|
|
RBL1
|
retinoblastoma-like 1
|
|
RBM14
|
RNA binding motif protein 14
|
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region
|
|
REG4
|
regenerating islet-derived family, member 4
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELN
|
reelin
|
|
REST
|
RE1-silencing transcription factor
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RHOA
|
ras homolog family member A
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RIPK2
|
receptor-interacting serine-threonine kinase 2
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RND2
|
Rho family GTPase 2
|
|
RNF114
|
ring finger protein 114
|
|
RNU11
|
RNA, U11 small nuclear
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
RPRD1B
|
regulation of nuclear pre-mRNA domain containing 1B
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
S100A10
|
S100 calcium binding protein A10
|
|
S100A4
|
S100 calcium binding protein A4
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
|
|
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINB7
|
serpin peptidase inhibitor, clade B (ovalbumin), member 7
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SERPINF2
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2
|
|
SERPINI1
|
serpin peptidase inhibitor, clade I (neuroserpin), member 1
|
|
SFPQ
|
splicing factor proline/glutamine-rich
|
|
SFTPA1
|
surfactant protein A1
|
|
SFTPB
|
surfactant protein B
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SGK223
|
homolog of rat pragma of Rnd2
|
|
SH3GLB1
|
SH3-domain GRB2-like endophilin B1
|
|
SH3PXD2A
|
SH3 and PX domains 2A
|
|
SHOX
|
short stature homeobox
|
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1
|
|
SIRT1
|
sirtuin 1
|
|
SIRT2
|
sirtuin 2
|
|
SIRT3
|
sirtuin 3
|
|
SKI
|
SKI proto-oncogene
|
|
SLC25A4
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4
|
|
SLC26A8
|
solute carrier family 26 (anion exchanger), member 8
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD6
|
SMAD family member 6
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMPD3
|
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II)
|
|
SNAI2
|
snail family zinc finger 2
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing
|
|
SOS1
|
son of sevenless homolog 1 (Drosophila)
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX3
|
SRY (sex determining region Y)-box 3
|
|
SP1
|
Sp1 transcription factor
|
|
SP3
|
Sp3 transcription factor
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPATA12
|
spermatogenesis associated 12
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRA1
|
steroid receptor RNA activator 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRXN1
|
sulfiredoxin 1
|
|
SRY
|
sex determining region Y
|
|
SS18
|
synovial sarcoma translocation, chromosome 18
|
|
SSRP1
|
structure specific recognition protein 1
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STK3
|
serine/threonine kinase 3
|
|
SYK
|
spleen tyrosine kinase
|
|
SYN1
|
synapsin I
|
|
SYNPO2
|
synaptopodin 2
|
|
TAB2
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2
|
|
TAB3
|
TGF-beta activated kinase 1/MAP3K7 binding protein 3
|
|
TAF4
|
TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 135kDa
|
|
TAF4B
|
TAF4b RNA polymerase II, TATA box binding protein (TBP)-associated factor, 105kDa
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TARDBP
|
TAR DNA binding protein
|
|
TBX5
|
T-box 5
|
|
TCF12
|
transcription factor 12
|
|
TCF3
|
transcription factor 3
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFAP4
|
transcription factor AP-4 (activating enhancer binding protein 4)
|
|
TFCP2
|
transcription factor CP2
|
|
TFCP2L1
|
transcription factor CP2-like 1
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TH
|
tyrosine hydroxylase
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THPO
|
thrombopoietin
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TICAM1
|
toll-like receptor adaptor molecule 1
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TMSB4Y
|
thymosin beta 4, Y-linked
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TP63
|
tumor protein p63
|
|
TPX2
|
TPX2, microtubule-associated
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRH
|
thyrotropin-releasing hormone
|
|
TRIB1
|
tribbles pseudokinase 1
|
|
TRIM28
|
tripartite motif containing 28
|
|
TRIM33
|
tripartite motif containing 33
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPM3
|
transient receptor potential cation channel, subfamily M, member 3
|
|
TRPM4
|
transient receptor potential cation channel, subfamily M, member 4
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV3
|
transient receptor potential cation channel, subfamily V, member 3
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TSC2
|
tuberous sclerosis 2
|
|
UBP1
|
upstream binding protein 1 (LBP-1a)
|
|
UGT2B15
|
UDP glucuronosyltransferase 2 family, polypeptide B15
|
|
UGT2B17
|
UDP glucuronosyltransferase 2 family, polypeptide B17
|
|
UNC119
|
unc-119 homolog (C. elegans)
|
|
UNC5CL
|
unc-5 homolog C (C. elegans)-like
|
|
USF1
|
upstream transcription factor 1
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VCP
|
valosin containing protein
|
|
VDAC1
|
voltage-dependent anion channel 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VENTX
|
VENT homeobox
|
|
VNN2
|
vanin 2
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
VTN
|
vitronectin
|
|
VWF
|
von Willebrand factor
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
XBP1
|
X-box binding protein 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
YY1
|
YY1 transcription factor
|
|
ZBP1
|
Z-DNA binding protein 1
|
|
ZBTB2
|
zinc finger and BTB domain containing 2
|
|
ZCCHC12
|
zinc finger, CCHC domain containing 12
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZNF143
|
zinc finger protein 143
|
|
ZNF148
|
zinc finger protein 148
|
|
ZNF268
|
zinc finger protein 268
|
|
ZNF652
|
zinc finger protein 652
|